Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial

Colombo, Nicoletta; Biagioli, Elena ✉; Harano, Kenichi; Galli, Francesca; Hudson, Emma; Antill, Yoland; Choi, Chel Hun; Rabaglio, Manuela; Marme, Frederic; Marth, Christian; Parma, Gabriella; Farinas-Madrid, Lorena; Nishio, Shin; Allan, Karen; Lee, Yeh Chen; Piovano, Elisa; Pardo, Beatriz; Nakagawa, Satoshi; Mcqueen, John; Zamagni, Claudio; Manso, Luis; Takehara, Kazuhiro; Tasca, Giulia; Ferrero, Annamaria; Tognon, Germana; Lissoni, Andrea Alberto; Petrella, Mariacristina; Laudani, Maria Elena; Rulli, Eliana; Uggeri, Sara; Ginesta, M. Pilar Barretina; AtTEnd Study Grp [Kollaborációs szervezet]